Frisch-Volkovich Stick

Frisch-Wolkovich bacillus (Klebsiella Rhinoscleromatis) is a bacterium that causes rhinoscleroma - chronic inflammation of the mucous membrane of the nose and paranasal sinuses. This bacterium was first described in 1882 and named after the German physician Alexander Frisch and the Soviet surgeon Nikolai Volkovich.

Frisch-Wolkovich rod is a gram-negative rod that has the form of cocci. It ranges in size from 0.5 to 2.0 microns and forms spores. This rod can be found in sputum, nasal mucus and on the surface of the skin. It can also be found in soil and water.

The main symptom of rhinoscleroma is thickening of the nasal mucosa, which leads to narrowing of the nasal passages and difficulty breathing. Pain in the nose and paranasal sinuses, as well as nasal discharge, may also occur.

Treatment for rhinoscleroma involves the use of antibiotics such as penicillin or erythromycin. Surgery may also be required to remove thickened areas of the mucosa.

However, rhinoscleroma can lead to serious complications such as damage to the lungs, heart and other organs. Therefore, if you suspect rhinoscleroma, you should consult a doctor for diagnosis and treatment.

Klebsiella rhinoscleromatis (K. rhinoscleromatis) is a bacterial bacillus that causes rhinoscleroma, a chronic inflammatory disease of the nasal mucosa. The name comes from the Latin words "rhino" - nose and "scleroma" - scleroma - the name given in 1870, when the connection between infection and disease of the nose was first discovered.

K. rhinoscleromatis is a Gram-negative rod that can grow on common media such as blood agar or Smith's medium. It can be found in air, water, soil and other media. The infection is usually transmitted through respiratory droplets, contact with contaminated surfaces, or inhalation of dust containing bacteria.

Clinical manifestations of rhinoscleroma can vary from mild to severe forms. Patients may experience nasal congestion, runny nose, nasal discharge, and difficulty breathing. In some cases, nasal deformities may develop, such as thickening and narrowing of the nostrils, a deviated nasal septum, and scarring of the nasal mucosa.

Treatment of rhinoscleroma includes the use of antibiotics such as penicillin, cephalosporins or macrolides. Topical corticosteroid medications may also be used to reduce inflammation and swelling. In severe cases, surgery may be required to remove scarring and restore normal nasal breathing.

Prevention of rhinoscleroma involves maintaining environmental hygiene, avoiding contact with dust and using protective masks when working with materials containing bacteria. It is also important to regularly screen for K. rhinoscleromatis infection in patients with chronic nasal disease.